{"abstract": "Johnson & Johnson, the U.S. health products company, said Friday that it was in advanced talks to offer for the 82 percent of Crucell, a Dutch biopharmaceutical firm, that it does not already own, in what would be a 1.75 billion euro deal.", "web_url": "https://dealbook.nytimes.com/2010/09/17/johnson-johnson-bids-2-3-billion-for-crucell/", "snippet": "Johnson & Johnson, the U.S. health products company, said Friday that it was in advanced talks to offer for the 82 percent of Crucell, a Dutch biopharmaceutical firm, that it does not already own, in what would be a 1.75 billion euro deal.", "lead_paragraph": "Johnson & Johnson, the American health products company, said Friday that it was in advanced talks to bid for the 82 percent of Crucell, a Dutch biopharmaceutical firm, that it does not already own, in what would be a 1.75 billion euro ($2.3 billion) deal.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Johnson & Johnson Mulling $2.3 Billion Crucell Bid", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2010-09-17T09:54:39+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Chris V. Nicholson", "person": [{"firstname": "Chris", "middlename": "V.", "lastname": "Nicholson", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "", "_id": "nyt://article/a72f448a-7365-5c1e-9af7-259c10f6abb3", "word_count": 296, "uri": "nyt://article/a72f448a-7365-5c1e-9af7-259c10f6abb3"}